-
Malaria Vaccine? Genetic Engineering Turns Parasite Into Vaccine Candidate
Malaria is one of the Great Diseases. This mosquito-borne illness killed some 627,000 people in 2012, most of them children in sub-Saharan Africa. Efforts in the last decade have cut mortality rates for the disease by an impressive 45 percent, but malaria continues to be a massive public health burden wherever it persists.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Ebola Vaccine Trial in Africa May Support More Potent Version
An experimental Ebola vaccine showed it was safe and generated an immune response in healthy Ugandan adults in a clinical trial that bodes well for a more potent version undergoing testing.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
The Limits of Tiered Pricing (Part 2): Harvard’s Suerie Moon says policy tweaks could help ensure access to medicine
In Part 2 of a two-part post, Harvard’s Suerie Moon suggests four ways tiered-pricing policies for pharmaceuticals might be improved in the short-to-medium term, and also highlights some alternatives – including rewarding innovation.
- Categories
- Health Care
- Tags
- vaccines
-
Are We On the Road to an HIV Vaccine?
"It only takes one virus to get through for a person to be infected," explained Dr. John Mascola. This is true of any viral infection, but in this instance, Mascola is referring to HIV and his ongoing efforts to develop a vaccine against the virus. "It's been so difficult to make an HIV/AIDS vaccine."
- Categories
- Health Care
- Tags
- vaccines
-
Race to Make Ebola Vaccine Pits Crazy Timeline Against Maddening Obstacles
Refrigeration is just one of the myriad challenges for GlaxoSmithKline Plc and other companies racing to create vaccines to fight Ebola. They’re facing issues ranging from packaging the drug in tiny glass vials for distribution, to assembling fleets of trucks and motorbikes to transport it along potholed roads, to monitoring subjects in a Swiss lakeside city to test the vaccine ultimately destined for villages in the African jungle.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Business Models, Best Practices and Measures in Access to Medicine: Index to be released Monday ranks pharmaceutical companies’ efforts to improve availability in developing countries
The Access to Medicine Index, which is published every two years and independently ranks pharmaceutical companies’ efforts to improve access to medicine in developing countries, will be released on Monday.
- Categories
- Health Care
-
Supply Chains for Global Health: Learning from Starbucks and Microsoft to get life-saving commodities where they’re needed, when they’re needed
Whether it is vaccines in Nigeria, family planning and essential medicines in Ethiopia, or HIV medications in Tanzania, supply chain managers need to have a solid understanding of product availability and supply chain processes in order to respond to people’s needs.
- Categories
- Health Care
- Tags
- supply chains, vaccines
-
Shaping the Market for Global Health Data: Why collecting information on lower-income countries should be ‘first order of business’
The most valuable currency in global health programs today is accurate and reliable data, but such data doesn’t exist for most low-income and lower-middle-income countries – primarily because it’s expensive. The authors discuss why, and how, more data might become available.
- Categories
- Health Care
- Tags
- supply chains, vaccines